Medicated diet composition for treating cold cough, and preparation method therefor and use thereof

MYPI2025004367A0Undetermined Publication Date: 2024-07-20GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025004367
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-01-20
Filing Date
2024-03-19
Publication Date
2024-07-20

AI Technical Summary

Technical Problem

Due to the shortage of drug resources and weak medical resources, patients infected with the new coronavirus in rural areas have difficulty in receiving timely and effective treatment. There is a lack of a convenient and effective medicinal dietary composition to relieve symptoms such as coughs.

Method used

A medicated dietary composition composed of Chinese medicinal materials such as kumquat, ginger, tangerine peel and Platycodon grandiflorum is prepared by decoction, and its functions of dispersing cold, relieving the surface, resolving phlegm and relieving cough are used to provide a convenient and easy-to-operate medicated diet for the treatment of cold cough. composition.

Benefits of technology

The medicated dietary composition can quickly improve the symptoms of cold cough caused by the new coronavirus infection, significantly improve the disappearance rate of cough symptoms, is suitable for areas with shortage of drug resources, provides a feasible medication option, and improves treatment problems in rural areas.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

A medicated diet composition for treating a cold cough, and a preparation method therefor and use thereof are provided. The medicated diet composition for treating a cold cough includes the following raw materials in parts by mass: 50-100 parts of kumquat, 10-20 parts of fresh ginger, 2-3 parts of Citri reticulatae pericarpium, and 5-10 parts of Platycodonis radix. The medicated diet composition of the present disclosure can rapidly improve symptoms of the cold cough caused by SARS-CoV-2 infection, especially suitable for patients with the cold cough caused by SARS-CoV-2 infection in areas with relatively scarce pharmaceutical resources, limited medical facilities, or difficulties in obtaining medicine.
Need to check novelty before this filing date? Find Prior Art

Description

Medicinal diet composition for treating cold cough, preparation method and application thereof Technical Field

[0001] The present invention belongs to the technical field of traditional Chinese medicine, and in particular relates to a medicinal food composition for treating cold cough, and a preparation method and application thereof. Background Art

[0002] [Corrected on 28.03.2024 according to Rule 26] With the continuous mutation of the new coronavirus, especially since the prevalence of the Omicron strain, the virus's infectivity is increasing, but its pathogenicity is gradually weakening. The clinical symptoms of most patients infected with the new coronavirus are mainly upper respiratory and digestive tract symptoms, and the incidence of pneumonia has been greatly reduced. Traditional Chinese medicine has been deeply involved in the prevention and treatment of new coronavirus infection throughout the process, showing significant advantages.

[0003] Coughing is a common symptom of COVID-19 infection. Traditional Chinese Medicine (TCM) offers unique advantages in treating coughs caused by COVID-19, and a number of TCM herbal remedies are currently available. However, compared to urban areas, rural areas face a relative shortage of preventive medications, limited medical resources, and limited access to medication. Consequently, COVID-19 patients in rural areas often fail to receive timely and effective treatment, leading to further progression of their condition. Traditional Chinese Medicine (TCM) believes that "medicine and food share a common origin," equating diet with medicine. Throughout history, physicians have emphasized the role of diet in treating illnesses, in addition to medication. Dietary therapy in TCM has a deep cultural and historical heritage. Therefore, in areas with relatively limited access to medication, limited medical resources, and limited access to medication, dietary therapy using local herbs and ingredients can alleviate symptoms such as coughs caused by COVID-19. Currently, a readily available and effective dietary remedy is lacking.

[0004] Summary of the Invention

[0005] The first object of the present invention is to provide a medicinal diet composition for treating cold cough, the second object of the present invention is to provide a preparation method of the medicinal diet composition, and the third object of the present invention is to provide an application of the medicinal diet composition.

[0006] According to a first aspect of the present invention, a medicated diet composition for treating cold cough is provided, wherein the raw materials thereof comprise, by weight, 50-100 parts of kumquat, 10-20 parts of ginger, 2-3 parts of tangerine peel, and 5-10 parts of platycodon.

[0007] The present invention targets the cold cough caused by novel coronavirus infection, which is mainly manifested by cough, itchy throat, coughing up white sputum, fear of cold, headache, clear runny nose, cold and painful limbs, white or greasy tongue, and floating and tight pulse.

[0008] In this formula, kumquat, with its warm nature and pungent and sweet flavors, regulates qi, relieves depression, and helps digestion and resolve phlegm, making it the main herb. Tangerine peel, with its bitter, pungent, and warm properties, regulates qi and strengthens the spleen, dispels dampness, and resolves phlegm. This enhances the main herb's ability to regulate qi and resolve phlegm, making it the assistant herb. Platycodon grandiflorum, which invigorates the lungs and helps dispel external pathogens, serves as the adjuvant. Ginger, with its pungent and warm nature, enters the lungs to dispel cold and stop vomiting, relieve depression, and eliminate phlegm, making it the guiding herb. Together, these herbs dispel cold, resolve phlegm, and relieve cough, effectively alleviating the cold cough symptoms associated with novel coronavirus infection.

[0009] The sources of raw materials for this recipe are as follows:

[0010] Kumquat: The fruit of Fortunella margarita (Lour.) Swingle, Rutaceae.

[0011] Ginger: The fresh rhizome of Zingiber officinale Rosc., a plant of the ginger family.

[0012] Tangerine peel: the dried mature peel of the Rutaceae plant Citrus reticulata Blanco and its cultivated varieties.

[0013] Platycodon: The dried root of Platycodon grandiflorum (Jacq.) A.DC., a plant of the Campanulaceae family.

[0014] In some embodiments, the medicinal diet composition for treating cold cough comprises, by weight, 100 parts of kumquat, 20 parts of ginger, 3 parts of tangerine peel, and 10 parts of platycodon.

[0015] In some embodiments, the medicinal diet composition for treating cold cough comprises, by weight, 50 parts of kumquat, 10 parts of ginger, 2 parts of tangerine peel, and 5 parts of platycodon.

[0016] In some embodiments, food-acceptable seasonings or medically acceptable excipients are also included.

[0017] According to a second aspect of the present invention, there is provided a method for preparing the above-mentioned medicinal diet composition for treating cold cough, comprising the following steps:

[0018] Slice the ginger but do not cut the kumquat, then mix the sliced ​​ginger, kumquat, tangerine peel and platycodon, add 3-5 times the weight of water and boil for 30-60 minutes to obtain the product.

[0019] The present invention does not cut the kumquat when preparing the medicinal food composition, thereby being able to more effectively boil and extract the effective ingredients in the kumquat peel and pulp, making the medicinal food taste sweet and sour, and not only being able to focus on relieving cough and reducing phlegm, but also being able to better cooperate with other ingredients to exert the therapeutic effects of dispelling cold, relieving exterior symptoms, reducing phlegm and relieving cough.

[0020] According to a third aspect of the present invention, there is provided the use of the above-mentioned medicinal diet composition for treating cold cough in the preparation of a medicament for treating novel coronavirus infection.

[0021] According to a fourth aspect of the present invention, there is provided the use of the above-mentioned medicinal diet composition for treating cold cough in the preparation of a medicine for treating cough caused by novel coronavirus infection, accompanied by itchy throat, coughing up white sputum or fear of cold.

[0022] Compared with the prior art, the present invention has the following beneficial effects:

[0023] (1) The medicinal diet composition of the present invention can quickly improve the symptoms of cold cough caused by novel coronavirus infection, and is particularly suitable for patients with cold cough caused by novel coronavirus infection in areas where drug resources are relatively scarce, medical resources are relatively weak, and purchasing medicines is relatively difficult.

[0024] (2) The present invention selects four substances that are both food and Chinese medicinal materials to form a medicinal diet composition, selects kumquat, a common food ingredient on the market, as the main medicine, and combines it with ginger, tangerine peel, and platycodon, which are common Chinese medicinal materials with medicinal and edible properties on the market. The ingredients are convenient to obtain, easy to operate, delicious, and inexpensive, providing a feasible medication option for patients with cold cough after infection with the new coronavirus, and to a great extent improving the problem of shortage of drug resources and difficulty in purchasing medicines in rural areas. DETAILED DESCRIPTION

[0025] The present invention will be further described in detail below in conjunction with specific examples. It is worth noting that the following examples are only for better explanation of the present invention and are not intended to limit the scope of protection of the present invention. The undisclosed process steps in the examples are prior art. Unless otherwise specified, the following raw materials are commercially available.

[0026] Example 1

[0027] The medicinal diet for treating cold cough of this embodiment comprises the following raw materials in parts by mass: 100 g kumquat, 20 g ginger, 3 g tangerine peel, and 10 g platycodon grandiflorum.

[0028] The preparation method comprises the following steps:

[0029] Slice the ginger but do not cut the kumquat. Then mix the sliced ​​ginger with the kumquat, tangerine peel, and platycodon grandiflorum, add to 500mL of water, and boil for 40 minutes until the volume reaches 200mL.

[0030] The medicated diet prepared in this embodiment is suitable for adult patients with cold cough caused by novel coronavirus infection. The dosage of one dose is 200 mL, and one dose is taken once a day, divided into 3-4 doses.

[0031] Example 2

[0032] The medicinal diet for treating cold cough of this embodiment comprises the following raw materials in parts by mass: 50 g kumquat, 10 g ginger, 2 g tangerine peel, and 5 g platycodon grandiflorum.

[0033] The preparation method comprises the following steps:

[0034] Slice the ginger but do not cut the kumquat. Then mix the sliced ​​ginger with the kumquat, tangerine peel and platycodon grandiflorum, add to 300mL of water, and boil for 40 minutes until the volume reaches 150mL.

[0035] The medicated diet prepared in this embodiment is suitable for children with a cold cough caused by a novel coronavirus infection. The dosage of one dose is 150 mL, and one dose is taken once a day, divided into 3-4 doses.

[0036] Next, to illustrate the therapeutic effect of the medicinal diet composition of the present invention on the cold cough caused by novel coronavirus infection, a clinical trial was conducted using the medicinal diet prepared in Examples 1-2.

[0037] 1. Relevant standards

[0038] (1) Diagnostic criteria

[0039] 1. Western medicine disease diagnosis

[0040] Refer to the "Diagnosis and Treatment Plan for New Coronavirus Infection (Trial Ninth Edition)", have epidemiological history and clinical manifestations, and meet the etiological evidence (positive nucleic acid test or antigen test for new coronavirus pneumonia).

[0041] The disease is classified into mild and common types according to the "Diagnosis and Treatment Plan for Novel Coronavirus Infection (Trial Ninth Edition)".

[0042] 2. Diagnostic criteria for TCM syndromes

[0043] Hot cough: cough and sore throat, bitter taste in the mouth with yellow phlegm, fever or irritability, red tongue or red tongue, yellow tongue coating, and floating and rapid pulse.

[0044] Cold cough: cough with itchy throat, white phlegm, fear of cold, white or greasy tongue, floating and tight pulse, accompanied by headache, clear runny nose, cold and painful limbs.

[0045] (2) Inclusion criteria

[0046] 1. Those who test positive for novel coronavirus pneumonia nucleic acid test or antigen test;

[0047] 2. According to the diagnostic criteria of the "Diagnosis and Treatment Plan for Novel Coronavirus Infection (Trial 9th ​​Edition)", the clinical type is mild or common;

[0048] 3. Cough as the main symptom;

[0049] 4. The patient or his / her legal representative signs the informed consent form.

[0050] (3) Exclusion criteria

[0051] 1. People with allergies or those who are allergic to the medicinal taste of the medicinal diet composition of the present invention;

[0052] 2. Patients with chronic lung diseases such as bronchiectasis, bronchopneumonia, chronic lung abscess, chronic cough for more than 8 weeks, chronic pharyngitis with cough, lung cancer, respiratory bacterial infection, etc., which may affect the judgment of cough symptoms;

[0053] 3. Heavy smokers (years of smoking × number of cigarettes smoked per day ≥ 400, such as smoking history ≥ 20 years, ≥ 20 cigarettes per day);

[0054] 4. Unable to cooperate with the follow-up;

[0055] 5. Pregnant female subjects;

[0056] 6. Patients with severe underlying diseases or acute exacerbation of chronic diseases, such as acute heart failure;

[0057] 7. Participants in or currently participating in other clinical trials within one month before this study.

[0058] 2. Case Sources and Grouping

[0059] The cases came from patients infected with the new coronavirus in Yangshuo Town, Baisha Town, Fuli Town, Gaotian Town, and Puyi Township, Yangshuo County, Guangxi.

[0060] The experiment was based on a real-world observational study design, with an experimental group: control group ratio of 2:1; with a two-sided α=0.05 and β=0.10, that is, at a test level of 0.05 and a confidence level of 90%, 483 cases were required in the experimental group and 242 cases in the control group; considering a 15% loss to follow-up rate, 555 cases were required in the experimental group and 278 cases were required in the control group, for a total of 833 samples.

[0061] 3. Observation Indicators and Timing

[0062] (1) General information, including age, gender, height, weight, past medical history, onset time, whether or not COVID-19 vaccine was received, smoking history, etc., was collected during the first observation.

[0063] (2) Clinical symptoms and signs: including fever, cough, shortness of breath, sore throat, diarrhea, nasal congestion and runny nose, fatigue, poor appetite, headache, muscle pain, chest tightness, chest pain, loss of taste, loss of smell, etc.; collected every day during treatment.

[0064] (3) Cough severity score sheet, as shown in Table 1, was collected daily during the treatment period. The treatment period was 5 days, and patients whose cough symptoms disappeared during the first 5 days were followed up on the 6th and 7th days.

[0065] Table 1 Cough severity score table

[0066] (4) Treatment plan, including whether to use other drugs for the treatment of novel coronavirus infection or symptomatic treatment.

[0067] (5) Conditions after taking the medicine, collected every day during the treatment period.

[0068] IV. Treatment Plan

[0069] 1. Conventional treatment plan: Refer to the "Diagnosis and Treatment Plan for Novel Coronavirus Pneumonia (Trial Ninth Edition)" for diagnosis and treatment, including symptomatic antipyretic, analgesic, and anti-vomiting measures.

[0070] 2. Treatment plan based on TCM syndrome differentiation:

[0071] (1) Cold cough: Adult patients took the medicated diet prepared in Example 1, with a dosage of 200 ml, once a day, divided into 3-4 doses. Children took the medicated diet prepared in Example 2, with a dosage of 150 ml, once a day, divided into 3-4 doses. The treatment period was 5 days.

[0072] (2) Heat cough: Adults: Add 100g kumquat, 50g water chestnut, 10g northern radix adenophorae, 10g platycodon grandiflorum, add 500ml water, decoct for 40 minutes until the solution is reduced to 200ml. The dosage is 200ml. Take one dose per day, divided into 3-4 times. Children: Add 50g kumquat, 30g water chestnut, 5g northern radix adenophorae, 5g platycodon grandiflorum, add 300ml water, decoct for 40 minutes until the solution is reduced to 150ml. The dosage is 150ml. Take one dose per day, divided into 3-4 times. Treatment period is 5 days.

[0073] In principle, patients who adopt TCM syndrome differentiation and treatment plan should not take other Chinese medicines for cough and phlegm.

[0074] Patients in the control group received conventional treatment, while those in the experimental group received Traditional Chinese Medicine (TCM)-based treatment. Patients were assigned to either the control or experimental group based on the treatment regimen they received, and efficacy indicators were compared between the groups. The primary efficacy indicator was the time it took for cough symptoms to disappear.

[0075] 5. Statistical Methods

[0076] All data were analyzed using SPSS and R. Normally distributed data were expressed as mean ± standard deviation, and intergroup comparisons were performed using t-tests or analysis of variance. Nonnormally distributed data were analyzed using nonparametric tests. Categorical variables were expressed as numbers and percentages, and intergroup comparisons were performed using the chi-square test or the exact probability method. Propensity score matching and Cox regression analysis were used to compare the time to resolution of cough symptoms between the two groups. Propensity score matching was performed using nearest neighbor matching, with a caliper value of 0.2. A P value of < 0.05 was considered statistically significant.

[0077] 6. Test Results

[0078] A total of 1,434 patients were followed up. After excluding patients without cough at baseline (627 patients), those with concurrent chronic lung disease (13 patients), and those who were heavy smokers (30 patients), a total of 763 patients were included, including 282 in the control group and 481 in the experimental group. In the experimental group, 204 patients had a fever cough and 225 had a cold cough. Fifty-two patients had no record of either a cold cough or a fever cough and were not included in the analysis.

[0079] To illustrate the therapeutic effect of the medicinal diet composition of the present invention on the cold cough caused by novel coronavirus infection, the cold cough patients were divided into a medicinal diet composition group, and then the control group and the medicinal diet composition group were analyzed as follows:

[0080] 1. Baseline analysis

[0081] The baseline information of the patients is shown in Table 2.

[0082] Table 2 Baseline comparison between the control group and the medicinal diet composition group

[0083] Note: Follow-up time = last follow-up date - baseline form completion date.

[0084] As can be seen from Table 2, the median follow-up time of the medicinal diet composition group was 6 days, and the median follow-up time of the control group was 7 days. The patients in the medicinal diet composition group had a longer coughing time when they were enrolled, and there were more smoking patients. The difference between the two groups was statistically significant (P < 0.05).

[0085] 2. Comparison of the two groups before and after propensity score matching

[0086] Propensity score matching was performed based on age, gender, presence of underlying diseases, time from first cough to enrollment, number of vaccinations, smoking status, use of cough suppressants before enrollment, and cough symptom score before enrollment. After matching, the two groups had 180 cases each. The two groups were balanced and comparable except for whether cough suppressants were used before enrollment. The comparison results of the two groups after propensity score matching are shown in Table 3:

[0087] Table 3 Comparison of the two groups after propensity score matching

[0088] Note: SMD, standardized mean difference. SMD < 0.1 indicates that the two groups are balanced and comparable.

[0089] 3. Comparison of results after matching

[0090] The regression analysis after propensity score matching between the two groups is shown in Table 4:

[0091] Table 4 Regression analysis after propensity score matching between the two groups

[0092] Notes: (1) HR: Hazard ratio. HR>1 indicates that the medicinal diet composition group is more likely to have the cough symptom disappear than the control group.

[0093] (2) Definition of cough disappearance: For patients with a total score of >5 on the cough severity rating scale shown in Table 1, the date from the first dose to the first time a score of 5 on the cough severity rating scale shown in Table 1 appears after the dose;

[0094] (3) The median follow-up time for the medicinal diet composition group was 6 days, and the median follow-up time for the control group was 7 days.

[0095] As can be seen from Table 4, after a median follow-up of 6 days for the medicinal diet composition group and 7 days for the control group, the disappearance of cough symptoms in the medicinal diet composition group was 1.28 times that of the control group, with 95% CI: (1.01, 1.62).

[0096] 4. Comparison of secondary indicators between the two groups after propensity score matching

[0097] The comparison results of the secondary indicators of the two groups after propensity score matching are shown in Table 5:

[0098] Table 5 Comparison of secondary indicators between the two groups after propensity score matching

[0099] Notes: (1) CET: Cough Evaluation Test score, scored according to Table 1;

[0100] (2) There were cases of loss to follow-up on the 3rd and 5th days, so the number of follow-up on the 3rd and 5th days was less than 180. The cough symptom disappearance rate on the 3rd day was a = 87 / 159 = 54.7%; b = 61 / 158 = 38.6%; the cough symptom disappearance rate on the 5th day was c = 85 / 161 = 52.8%; d = 89 / 147 = 60.5%;

[0101] (3) The treatment period was 5 days. Patients filled out the CET score sheet every day during the treatment. Patients whose cough symptoms disappeared in the first 5 days ended the follow-up on the 6th and 7th days. Therefore, the number of patients followed up on the 7th day was less than 180. The cough symptom disappearance rate on the 7th day was e = 39 / 88 = 44.3%; f = 88 / 105 = 83.8%.

[0102] As can be seen from Table 5, on the 3rd day after medication, the cough symptom disappearance rate in the control group was higher, and the difference was statistically significant; on the 5th day after medication, there was no statistically significant difference in the cough symptom disappearance rate between the two groups; on the 7th day after medication, the cough symptom disappearance rate in the medicinal diet composition group was higher than that in the control group (83.8% in the medicinal diet composition group vs 44.3% in the control group, P<0.001), and the difference between the two groups was statistically significant.

[0103] 5. Conclusion

[0104] After taking the medicated diet composition of the present invention, the rate of disappearance of cough symptoms in patients with a cold cough caused by the novel coronavirus infection was 1.28 (95% CI: 1.01, 1.62) times higher than that in the control group (median follow-up for the medicated diet composition group was 6 days, and for the control group was 7 days). Seven days after taking the medicated diet composition of the present invention, the rate of disappearance of cough symptoms in patients with a cold cough caused by the novel coronavirus infection was higher than that in the control group, and the difference was statistically significant. This indicates that the medicated diet composition of the present invention can significantly improve the symptoms of a cold cough caused by the novel coronavirus infection.

[0105] The above descriptions are only some specific embodiments of the present invention. For those skilled in the art, several modifications and improvements can be made without departing from the creative concept of the present invention, and these all fall within the scope of protection of the present invention.

Claims

1. A medicated diet composition for treating cold cough, characterized in that, Its raw material composition by mass parts includes: 50 - 100 parts of kumquats, 10 - 20 parts of ginger, 2 - 3 parts of dried tangerine peel, and 5 - 10 parts of platycodon root.

2. The medicated diet composition for treating cold cough according to claim 1, wherein, Its raw material composition by mass parts includes: 100 parts of kumquats, 20 parts of ginger, 3 parts of dried tangerine peel, and 10 parts of platycodon root.

3. The medicated diet composition for treating cold cough according to claim 1, wherein Its raw material composition by mass parts includes: 50 parts of kumquats, 10 parts of ginger, 2 parts of dried tangerine peel, and 5 parts of platycodon root.

4. The medicated diet composition for treating cold cough according to any one of claims 1-3, characterized in that, It also includes food - acceptable seasonings or pharmaceutically - acceptable excipients.

5. The preparation method of the medicated diet composition for treating cold cough according to any one of claims 1-4, characterized in that, It includes the following steps: Slice the ginger, do not cut the kumquats, then mix the sliced ginger with kumquats, dried tangerine peel, and platycodon root, add 3 - 5 times the weight of water and decoct for 30 - 60 minutes to obtain.

6. Use of the medicated diet composition for treating cold cough according to any one of claims 1 - 4 in the preparation of a drug for treating novel coronavirus infection.

7. Use of the medicated diet composition for treating cold cough according to any one of claims 1 - 4 in the preparation of a drug for treating cough caused by novel coronavirus infection, accompanied by itchy throat, coughing up white phlegm or fear of cold.